Director, Division of Movement Disorders – Position Overview 

Director, Division of Movement Disorders
Department of Neurology – University of Minnesota Medical School
Minneapolis, MN

Position Summary

The University of Minnesota Medical School (UMN) seeks an accomplished movement disorders neurologist to serve as Director, Division of Movement Disorders. This is a senior academic leadership role overseeing one of the nation’s most comprehensive clinical, research, and educational programs in movement disorders and neuromodulation.

The incoming leader will oversee a growing division with a strong clinical foundation, advanced neuromodulation surgery program, NIH-supported laboratories, and an ACGME-recognized Movement Disorders Fellowship.

Reporting directly to the Chair of the Department of Neurology, Jerrold L. Vitek, MD, PhD, a recognized neuromodulation pioneer, the Division Director of Movement Disorders will lead one of the nation’s premier translational ecosystems in Parkinson’s disease and neuromodulation. This leadership role advances clinical excellence, innovative neuromodulation therapies, multidisciplinary care, and NIH-funded research within a top-tier academic environment.

The division is currently leading and participating with several nationally distinguished resources—including the Morris K. Udall Center of Excellence in Parkinson’s Disease Research, the Neuromodulation Research Center (NMRC), the Movement Disorders and Motor Neurophysiology Laboratories, the Center for Neural Engineering and UMN’s world-leading Center for Magnetic Resonance Research (CMRR)—providing unparalleled opportunities for clinical and translational science and innovation in deep brain stimulation, gait and balance research, neurophysiology, imaging, and device-based therapy.

The Division Director will lead the Division of Movement Disorders in work that is also supported by a robust multidisciplinary team of neurologists, neurosurgeons, neuropsychologists, rehabilitation specialists, engineers, scientists, and research staff serving a diverse population of more than 3.5 million across the Twin Cities region. Protected academic and research time is available and will be structured to support leadership responsibilities, scholarly productivity, and program growth.

Key Program Highlights

• World-class leadership under Jerrold Vitek, MD, PhD, a global authority in DBS, neuromodulation, and basal ganglia research, and Director of the UMN Udall Center of Excellence.
• NINDS-designated Morris K. Udall Center of Excellence in Parkinson’s Disease Research—Advancing mechanistic understanding and next-generation neuromodulation therapies.
• Neuromodulation Research Center (NMRC): A national referral center with integrated neurology–neurosurgery–engineering collaboration, advanced intra-operative neurophysiology, adaptive/closed-loop DBS development, and strong industry partnerships.
• Movement Disorders and Motor Neurophysiology Laboratories, led by Colum MacKinnon, PhD and Scott Cooper, MD, PhD, supporting cutting-edge human motor control, gait, balance, cortical/subcortical physiology, quantitative kinematics/EMG, and advanced imaging studies.
• Robust multidisciplinary DBS program supported by 3 functional neurosurgeons, allied health, neuropsychology, PT/OT/SLP, and dedicated clinical research coordinators.
• Strong clinical trials and research infrastructure, supported by research leadership, Jeremy Duncan, PhD, Research Director, the MNDRIVE Brain Conditions Initiative, and department-wide regulatory/IRB support staff.
• ACGME-recognized Movement Disorders Fellowship, with one to two fellows training annually in a two-year program, supported by strong existing industry partnerships and the potential for future expansion (AbbVie, Abbott, Medtronic, Boston Scientific).
• Diverse patient population serving a clinic footprint both in the central University site and suburban clinical settings associated with M Health Fairview.
• Access to unmatched institutional research infrastructure, including the 10.5T human MRI at CMRR, biomedical engineering, neuroengineering, genomics, stem cell research, and statewide MnDRIVE partnerships.

Position Responsibilities

The Division Director will be charged with advancing UMN’s national leadership in movement disorders and neuromodulation while scaling clinical impact, research productivity, multidisciplinary collaboration, and program visibility. The Division Director will provide strategic leadership and oversight of the clinical, research, educational, and operational missions of the Division of Movement Disorders, including but not limited to:

• Lead and further grow the Division’s clinical programs, ensuring continued excellence and innovation in the diagnosis and management of Parkinson’s disease, tremor, dystonia, ataxia, atypical parkinsonism, and related disorders
• Expand and enhance the Division’s already strong clinical research and clinical trials portfolio, increasing participation in device-based, pharmacologic, neuromodulation, and translational studies, and integrating research efficiently within clinical workflows and with project principal investigators and research teams
• Foster and strengthen translational and clinical research programs, including deep brain stimulation (DBS), adaptive/closed-loop neuromodulation, neuroengineering partnerships, gait and balance circuitry research, advanced imaging/connectomics, and wearable/remote monitoring technologies.
• Cultivate a collaborative, inclusive, and high-performing culture, promoting excellent communication, interdisciplinary teamwork, and alignment across neurology, neurosurgery, neuropsychology, rehabilitation, engineering, and allied health teams.
• Mentor, recruit, and support faculty, fellows, and residents, promoting academic productivity, leadership development, and professional growth in movement disorders, neuromodulation, and clinical investigation.
• Collaborate with the Movement Disorders Fellowship Program Director, ensuring excellence in curriculum, trainee experience, recruitment, and strategic expansion toward two fellows per year.
• Partner closely with health system leadership and neurosurgery to optimize DBS workflows, referral networks, evaluation pathways, and patient experience, supporting continued growth of neuromodulation services and surgical volume.
• Support departmental and institutional leadership in strategic planning, resource allocation, quality improvement initiatives, and broader programmatic development across the Department of Neurology and the Medical School.
• Serve as the Division’s representative locally, regionally, and nationally, enhancing program visibility, cultivating referral relationships, and promoting the Division as a leader in movement disorders and neuromodulation.

Candidate Qualifications

Required Qualifications

• MD, DO, or equivalent degree; board-certified/board-eligible in Neurology by the American Board of Psychiatry and Neurology (ABPN).
• Fellowship training in Movement Disorders or equivalent advanced expertise, with demonstrated excellence in the diagnosis and management of Parkinson’s disease, tremor, dystonia, ataxia, and related conditions.
• Eligibility for medical licensure in the State of Minnesota.
• Strong clinical expertise in movement disorders.
• Proven track record of scholarly productivity—clinical, translational, or basic science—sufficient for appointment at the rank of Associate Professor or Professor on the clinical track.
• Demonstrated ability to lead or contribute to clinical research or clinical trials; experience integrating research workflows into clinical care is strongly preferred.
• Excellent communication skills with the ability to foster collaboration across neurology, neurosurgery, neuropsychology, rehabilitation, engineering, and allied health teams.
• A leadership style characterized by emotional intelligence, transparency, humility, and team-orientation, capable of cultivating a positive culture and guiding a diverse multidisciplinary workforce.
• Commitment to education, mentorship, and academic development of trainees, residents, fellows, and junior faculty.

Preferred Qualifications

• Prior leadership experience (e.g., fellowship director, section chief, PI of funded research, clinical trials leadership, or equivalent) in an academic medical center.
• Demonstrated ability to build high-quality referral relationships and represent a program regionally or nationally.
• Familiarity with NIH-funded research programs, clinical trial execution, regulatory processes, or multidisciplinary research collaborations.
• Experience managing or participating in fellowship programs, curriculum development, or graduate medical education leadership.
• Interest or experience in innovative care delivery models, remote monitoring, wearable technology, AI-driven programming, or patient-centered pathway design.
• Physician–scientist or clinical trialist background with the ability to bridge clinical care, translational research, and multidisciplinary collaboration.

Division Scale & Resources

The Division of Movement Disorders is supported by a highly collaborative and growing team that includes:

• Clinician-educators and physician-scientists with expertise in Parkinson’s disease, DBS programming, dystonia, tremor, ataxia, and atypical parkinsonism.
• Neurosurgeons with deep expertise in DBS implantation and neuromodulation.
• Neuropsychologists, PT/OT/SLP specialists, RN Care coordinators, clinic navigators (CMA/LPN) a dedicated DBS RN program manager, and a multidisciplinary consensus team.
• A large cohort of research scientists, including experts in electrophysiology, sleep physiology, neuroengineering, imaging/fiber-tracking, computational modeling, and closed-loop neuromodulation.
• A highly experienced team of clinical research coordinators, regulatory/IRB staff, and MNDRIVE-supported cores enabling efficient startup and conduct of clinical trials.
• Fellowship leadership with strong trainee engagement, robust clinical volumes, and opportunities to expand to two fellows annually.

Why University of Minnesota?

The University of Minnesota is home to one of the nation’s most comprehensive neuroscience and neuromodulation ecosystems. UMN hosts the Morris K. Udall Center of Excellence, the Neuromodulation Research Center, the Movement Disorders and Motor Neurophysiology Laboratories, and the world-leading Center for Magnetic Resonance Research (CMRR)—providing unmatched access to advanced neuroimaging, physiology, engineering, and translational research tools.

The Department of Neurology is nationally recognized for neuromodulation and movement disorders research and is strategically growing its clinical and translational footprint. With a strong referral base across the Twin Cities and broader Midwest, the Division serves over 3.5 million people, supporting substantial clinical volume and opportunities to expand clinical trials, neuromodulation programs, and subspecialty clinics.

Located in the vibrant Minneapolis–Saint Paul metropolitan area—home to Medical Alley, the highest concentration of medical device companies in the U.S.—UMN offers unique opportunities for industry collaboration, biomedical engineering partnership, device development, and innovation in movement disorders.

Strategic Opportunities for the Incoming Division Director

• Grow and systematize clinical trials infrastructure, leveraging existing MNDRIVE support and strong departmental research cores.
• Support the Movement Disorders Fellowship and strengthen clinical education across the residency program.
• Increase visibility and national branding of the UMN movement disorders program, capitalizing on Udall designation and strong outcomes data.
• Lead cross-disciplinary growth in neuromodulation—including device-based therapies, closed-loop DBS, gait/balance modulation, and AI-driven programming.
• Strengthen external partnerships (industry, referring systems, philanthropy, device manufacturers).
• Develop multidisciplinary care pathways including atypical parkinsonism, dystonia, ataxia, Huntington’s disease, and advanced therapeutics (e.g., infusion therapies, gene/stem-cell trials).
• Continue to expand the DBS surgical volume in partnership with neurosurgery and referring networks.

Bridge the gap between research and innovation as the Founding Director of the Center for Inflammation Sciences at the University of Minnesota Medical School.

Programmatic Overview

Overview of the Movement Disorders Division

The University of Minnesota’s Division of Movement Disorders is a highly collaborative, multidisciplinary program dedicated to outstanding clinical care, neuromodulation, and translational research. The Division’s faculty work closely with neurosurgery, neuropsychology, neuroradiology, rehabilitation, biomedical engineering, and allied health specialists to diagnose and manage the full spectrum of movement disorders, including Parkinson’s disease, tremor, dystonia, and ataxia.

The Division is embedded in one of the country’s most comprehensive academic neuroscience environments:

• 80 Neurology faculty, 30 adult and pediatric residents, 8 fellowship programs, and 100+ active research studies.
• A top 25 NIH-funded Neurology Department with nearly $13M in annual awards.
• Leadership under Jerrold L. Vitek, MD, PhD, internationally recognized neurologist and Director of the UMN Udall Center of Excellence.
• Deep integration with the Morris K. Udall Center of Excellence in Parkinson’s Disease Research, the Center for Magnetic Resonance Research (CMRR), and the statewide MnDRIVE Brain Conditions Initiative.

UMN Udall Center of Excellence

UMN is home to one of the nation’s premier Udall Centers, bringing together experts from the Medical School, College of Science and Engineering, and School of Public Health. The Center investigates the neural mechanisms of Parkinson’s disease, including gait, rigidity, bradykinesia, tremor, speech, and freezing of gait.
Key areas of focus include:

• Mechanisms underlying motor dysfunction and postural control
• Neural pathways affected by deep brain stimulation (DBS)
• Development of mobile and sensor-based technologies for gait and balance
• Translation of circuit-level insights into next-generation neuromodulation therapies

Neuromodulation Research Center (NMRC)

The Neuromodulation Research Center (NMRC) is a large collaborative entity that brings together University of Minnesota’s experts from neurology, neurosurgery, neuroscience, biomedical engineering, radiology and other disciplines that share a focus to advance the understanding of brain conditions and diseases and the neuromodulation therapies that improve them. The NMRC enables a unique “bench to bedside” experience that drives translational research and the University’s discovery and health innovation missions. Collaborations in the heart of Minnesota’s Medical Device Alley further enrich the center’s impact through external industry collaborations and the state’s MnDrive initiative.

Movement Disorders Laboratory

Led by Colum MacKinnon, PhD, the Movement Disorders Laboratory investigates the neurophysiology of movement impairment and develops novel interventions to improve mobility and quality of life. The Lab combines:

• High-resolution EEG, TMS, tDCS, and other non-invasive neurophysiology tools
• Advanced imaging and connectivity analysis in collaboration with CMRR
• Quantitative movement assessment (3D kinematics, kinetics, multichannel EMG)

Motor Neurophysiology Laboratory

Led by Scott Cooper, MD, PhD, the Motor Neurophysiology Laboratory investigates the extrapyramidal motor system in human subjects with an emphasis on disease states and neurosurgical therapies. The lab’s current focus is on the basal ganglia and on Parkinson’s disease with most of the work centered on deep brain stimulation (DBS).

The Lab combines:

• State-of-art methods for the quantitative assessment of gait and balance using large-scale treadmills and novel perturbation paradigms
• Patient-specific computational modelling of DBS
• Neural recordings of the basal ganglia

These translational environments create exceptional opportunities for clinical–research collaboration.

A welcoming view of the University of Minnesota campus in spring, representing the home of the prestigious Chair of Rehabilitation Medicine.

Department of Neurology

The Department of Neurology at the University of Minnesota has a long and distinguished history of leadership, innovation, and academic excellence. Founded in 1946, the Department quickly became a national force in neurology under the direction of A.B. Baker, MD, PhD, an internationally renowned neurologist who also founded the American Academy of Neurology (AAN) and served as its first president in 1948. Today, that legacy continues under the leadership of Jerrold L. Vitek, MD, PhD, a global authority in movement disorders and neuromodulation.

Key departmental strengths include:

• More than 80 faculty supporting over 3,000 inpatient evaluations and 10,000 outpatient visits annually
• A culture of innovation with nationally recognized contributions to neuromodulation, Parkinson’s disease research, and other neurological subspecialties
• Deep interdisciplinary collaboration across Neurosurgery, Psychiatry, Radiology/Neuroradiology, Biomedical Engineering, Genetics, Public Health, and key research centers

10 clinical divisions including general neurology, neurohospitalist medicine, stroke, neuro-critical care, epilepsy, behavioral neurology multiple sclerosis, neuromuscular medicine and pediatric neurology.  The department has 2 sleep neurologists who participate in Parkinson’s and memory clinical trials and 2 neuro-oncologists.  The Department’s collaborative research ecosystem spans Neurosurgery, Psychiatry, Radiology/Neuroradiology, Biomedical Engineering, Genetics, Public Health, and multiple major research centers, including the Center for Magnetic Resonance Research (CMRR), the Institute for Human Genetics, and the Brain Sciences Center/GRECC at the Minneapolis VA. New interdisciplinary programs, such as those in vestibular and balance disorders, continue to expand the Department’s clinical and scientific reach.

This legacy of innovation, multidisciplinary integration, and commitment to training the next generation of neurologists provides a strong foundation for the Division of Movement Disorders and its next leader.

University & Health System Overview

The University of Minnesota Medical School is a nationally recognized research institution with historic contributions to medical innovation—including the first open-heart surgery, first bone marrow transplant, and the world’s first stem cell institute. Its three campuses in Minneapolis–St. Paul, St. Cloud and Duluth support comprehensive medical education and training.

Fairview Health Services, the University’s current clinical partner, together with University of Minnesota Physicians, forms a large academic health system with 10 hospitals, 100+ primary care clinics, and statewide referral networks. University of Minnesota Medical Center (UMMC), ranked #1 for hospitals in the Twin Cities Metro, serves as a quaternary care destination for complex neurological and neurosurgical care.

University of Minnesota

Founded in 1888, the University of Minnesota Medical School educates students and graduate physicians, provides patient care, and performs biomedical and clinical research.

We offer medical, graduate and undergraduate degree programs, as well as continuing professional development. Our Medical School is one of the largest in the country, with two campuses based in the Twin Cities and Duluth, Minnesota. The Twin Cities campus is an interdisciplinary research center. Our Duluth campus educates 130 first and second-year medical students committed to practicing in rural or American Indian communities.

Research & Teaching

The University of Minnesota is a world-class research institution with a well-established medical school that dates back to 1888. The University pioneered medical discoveries like the first external pacemaker, the first successful bone marrow transplant, the first successful open-heart surgery, and the world’s first stem cell institute. The University of Minnesota’s Twin Cities campus also ranked No. 8 in public research institutions in the United States based on the Center for Measuring University Performance (CMUP)’s 2013 report.

Research is a critical element in the fight against neurological disease; it paves the way for the development and implementation of new therapies and provides opportunities to expand our academic mission. Our physicians pioneer new surgical therapies for Parkinson’s disease and dystonia and the application of deep brain stimulation for movement and psychiatric disorders, and multidisciplinary studies in diseases of muscle and nerve with a world-class Center for Magnetic Resonance Research (CMRR) illustrate the critical role played by research in the delivery of clinical care.

Unique Infrastructure & Research Strengths

UMN offers one of the country’s richest research environments for neurosciences and neuromodulation, supported by:

Institute for Translational Neuroscience (ITN)

The Institute for Translational Neuroscience (ITN) is a university-wide initiative established to accelerate the movement of basic neuroscience discoveries into clinical practice. ITN unites investigators across neuroengineering, neurodegeneration, neuromuscular disease, mental health, and imaging, providing a collaborative platform that supports translational research, clinical trials, and technology development. ITN’s integration with CMRR, Biomedical Engineering, and Neurosurgery positions UMN as a leader in moving cutting-edge neuroscience breakthroughs toward real-world application.

Biomedical Discovery District

The Biomedical Discovery District is a state-of-the-art, multi-building research complex designed to co-locate leading scientists from across the Academic Health Center. The BDD houses advanced laboratories focused on neuroscience, infectious disease, immunology, cancer, cardiovascular science, stem cells, and translational therapeutics. Its collaborative design fosters interdisciplinary teams and provides high-end research infrastructure that directly supports the growth of neuromodulation, movement disorders, and brain conditions research.

Center for Magnetic Resonance Research (CMRR)

The Center for Magnetic Resonance Research (CMRR) is one of the world’s premier imaging centers, home to the world’s first 10.5T human MRI system and multiple ultra–high field scanners (7T, 4T, 3T). CMRR develops cutting-edge MRI/MRS technology and advanced brain connectivity methods that uniquely enable mechanistic studies in Parkinson’s disease, gait/balance circuits, and neuromodulation. With major NIH support and internationally recognized faculty, CMRR provides unmatched imaging capabilities for translational neuroscience.

Neuromodulation Research Center and Lab (NRCL)

The Neuromodulation Research Center/Lab integrates neuroscience, neuroengineering, electrophysiology, and computational modeling to advance the science and technology of brain stimulation. NRCL conducts mechanistic studies of DBS, develops novel stimulation strategies, and evaluates new implantable technologies in partnership with the Minnesota Supercomputing Institute and industry collaborators. Its work directly supports innovation in adaptive/closed-loop DBS and positions UMN at the forefront of neuromodulation research.

Non-Human Primate Movement Disorders & Neuromodulation Program

The University of Minnesota maintains a robust non-human primate (NHP) research program that has been central to advancing our understanding of basal ganglia circuits, Parkinsonian gait, and the mechanisms of deep brain stimulation (DBS). Using the MPTP non-human primate model of Parkinson’s disease, UMN investigators have characterized gait progression, basal ganglia–brainstem circuitry, and the effects of targeted subthalamic and pallidal DBS—including novel paradigms such as coordinated reset and closed-loop stimulation.

This work is closely integrated with the Neuromodulation Research Center and the Preclinical Research Center, which is nationally recognized for modeling complex therapies in primate disease models.

Together, these programs provide a rare preclinical-to-clinical translational pipeline in movement disorders, directly informing human DBS targeting, stimulation strategies, and next-generation neuromodulation therapies.

Center for Neuroengineering (CNE)

The Center for Neuroengineering (CNE) brings together neuroscience, engineering, and clinical experts to develop next-generation neurotechnologies, including brain–machine interfaces and advanced neuromodulation platforms such as deep brain stimulation (DBS). As part of the Institute for Translational Neuroscience and affiliated with the Institute for Engineering in Medicine, CNE focuses on neural interfacing, neuromodulation, neuroimaging, and neural computation. Its close ties to Minnesota’s medical device industry create powerful opportunities to translate fundamental neuroscience discoveries into clinically impactful tools and therapies.

Center for Neurodegenerative Disease

The Center for Neurodegenerative Disease brings together basic scientists and clinical investigators working across Parkinson’s disease, ataxia, ALS, muscular dystrophies, and related disorders. The Center supports collaborative research funded by the NINDS Core Center program and integrates efforts with the UMN Udall Center, Ataxia Research Center, and Wellstone Muscular Dystrophy Center. This multidisciplinary environment strengthens discovery-to-clinic pipelines in movement disorders.

Stem Cell Institute

The Stem Cell Institute—the first interdisciplinary stem cell institute in the United States—focuses on developing regenerative and cellular therapies for neurological, cardiac, metabolic, and genetic diseases. With more than 50 investigators from 22 departments and a track record of translational innovation and patent generation, the Institute provides important resources for disease modeling, developmental biology, and future restorative therapies relevant to movement disorders.

Genomics Center

The University of Minnesota Genomics Center provides comprehensive genomics, sequencing, expression profiling, and nucleic acid analysis services. Equipped with state-of-the-art instrumentation, the Center supports large-scale omics studies, biomarker discovery, and precision medicine research. UMGC’s mandate to translate discovery into commercial technologies also strengthens partnerships between UMN neuroscience and the region’s robust biomedical industry.

MnDRIVE Brain Conditions Initiative

Minnesota’s Discovery, Research, and Innovation Economy (MnDrive) is a landmark partnership between the University and the state of Minnesota that aligns areas of University research strength with the state’s key and emerging industries to address grand challenges. In 2013, the Minnesota Legislature authorized an $18 million recurring annual investment in four research areas: robotics, environment, global food, and brain conditions. The Brain Conditions program advances diagnostics, neuromodulation, neural engineering, informatics, and neurorehabilitation through interdisciplinary projects linking UMN experts with industry and community partners. MnDRIVE provides seed funding, infrastructure, and translational support that directly accelerates movement disorders research and clinical innovation.

Human Connectome Project

UMN serves as a national hub for the Human Connectome Project, one of the largest NIH-funded efforts to map human brain circuitry. Using ultra–high field imaging and advanced diffusion/connectivity methods—many pioneered at UMN—the HCP produces foundational insights into human brain networks, variability, and disease mechanisms. This resource strengthens research in movement disorders, brain circuitry, DBS targeting, and neurophysiological modeling.

Minnesota Innovation Partnerships (MN-IP)

The Minnesota Innovation Partnerships (MN-IP) program accelerates collaboration between University of Minnesota researchers and industry by providing industry-friendly, streamlined licensing and research agreements. MN-IP lowers barriers for companies—ranging from Minnesota startups to global medical device leaders—to sponsor research, access UMN technologies, and rapidly translate discoveries into commercially viable products. Through these mechanisms, MN-IP strengthens UMN’s ability to partner with Minnesota’s world-class medical technology ecosystem, supporting innovation in neuromodulation, imaging, diagnostics, and device development.

Research Evaluation and Commercialization Hub (MINREACH)

The University of Minnesota is one of only three NIH-designated Research Evaluation and Commercialization Hub (REACH) sites in the nation. Supported by a combined $6 million in NIH and institutional funding, MINREACH provides commercialization expertise, project funding, and industry mentorship to advance diagnostics, therapeutics, neuromodulation technologies, and medical devices toward market. The program supports 10–20 translational projects annually and strengthens UMN’s pipeline for bringing neuroscience and engineering innovations—from DBS technologies to sensor-based systems—into clinical practice. MINREACH builds upon UMN’s strong legacy in biomedical entrepreneurship and its close proximity to the largest medical device cluster in the United States.

Location – Where You’ll Live

Twin Cities

This position is based in Minneapolis, Minnesota. The Twin Cities of Minneapolis and St. Paul have consistently been ranked among the best cities in the United States. The Twin Cities offer a progressive, rapidly growing metropolitan area of almost 3 million with varied cultural experiences and superb recreational activities. The warmth and friendliness of Minnesotans, in addition to world-class music, theater, art professional sports, dozens of lakes and a myriad of other opportunities, makes the Twin Cities a wonderful place to live and work.

Key attributes of Minneapolis/St. Paul

The University of Minnesota is located in the Twin Cities of Minneapolis and St. Paul, the birthplace and headquarters of the American Academy of Neurology (AAN). Four key attributes set the Minneapolis-Saint Paul region apart: a resilient, diverse economy anchored by 17 Fortune 500 companies, a penchant for innovation, one of the most highly educated workforces in the nations and an outstanding quality of life.

The Minneapolis-Saint Paul area is cosmopolitan at its heart and small town along its perimeter. The Twin Cities is the 16th largest metro area in the US, with a population of approximately 3.4 million people. It is the 2nd largest economic center in the Midwest, behind Chicago, and the second largest medical device manufacture center in North America. Minneapolis proper contains the 5th highest concentration of Fortune 500 companies in the country. The presence of the corporate headquarters for companies such as Target, US Bancorp, Xcel Energy and Ameriprise Financial provide a growing economy with great job opportunities for a candidate’s spouse or family. Additionally, an exciting arts and music scene, exceptional shopping, award-winning restaurants, wineries and craft breweries, and distinctive accommodations can be found throughout the area. Outdoor enthusiasts find plenty to do – even when temperatures dip, the variety of fun outdoor adventures does not. Sports fans cheer on their favorite team year-around. Big city bustle or small-town charm, anyone can find the activity that suits them in the Minneapolis – Saint Paul Area.

How to Apply

Academic Med

The University of Minnesota Medical School has retained Academic Med to lead this national search. Academic Med is a retained executive search firm specializing in the recruitment of physicians, scientists, and senior leaders for academic medical schools and health systems across the United States. This search is being led by Gentry Zacheis, President of Academic Med and supported by Stacy Olsen, Chief of Staff at Academic Med.

The Academic Med search team will work closely with Jerrold Vitek, MD, PhD, Chair of the Department of Neurology, and the appointed Search Committee members throughout the recruitment process.

Application Instructions

Please submit a CV and cover letter via email to Stacy Olsen, Chief of Staff at Academic Med via: so****@**********ed.com

Application review will begin immediately and will continue until the position is filled.

EEO/AA

The University of Minnesota is an Equal Employment Opportunity/Affirmative Action institution committed to excellence through diversity. The University does not discriminate on the basis of race, ethnicity, color, sex, religion, national origin, age, disability, genetic information, sexual orientation, gender identity or expression, pregnancy, marital status, military or veteran status, or any other status or classification protected by federal, state, or local law. All qualified candidates are encouraged to apply.